603367 Stock Overview
Manufactures and sells chemical drug preparations and health care products in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 603367 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Cisen Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.73 |
| 52 Week High | CN¥17.45 |
| 52 Week Low | CN¥11.34 |
| Beta | 0.21 |
| 1 Month Change | -2.00% |
| 3 Month Change | 11.44% |
| 1 Year Change | -7.17% |
| 3 Year Change | 4.33% |
| 5 Year Change | -14.45% |
| Change since IPO | -14.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603367 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.9% | -3.1% | -2.1% |
| 1Y | -7.2% | -4.4% | 9.8% |
Return vs Industry: 603367 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 603367 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 603367 volatility | |
|---|---|
| 603367 Average Weekly Movement | 4.8% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 603367 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603367's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 3,402 | Zhenxin Du | www.lkcisen.com |
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company’s chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd. Fundamentals Summary
| 603367 fundamental statistics | |
|---|---|
| Market cap | CN¥6.22b |
| Earnings (TTM) | CN¥529.01m |
| Revenue (TTM) | CN¥4.25b |
11.8x
P/E Ratio1.5x
P/S RatioIs 603367 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603367 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.25b |
| Cost of Revenue | CN¥1.82b |
| Gross Profit | CN¥2.44b |
| Other Expenses | CN¥1.91b |
| Earnings | CN¥529.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.17 |
| Gross Margin | 57.24% |
| Net Profit Margin | 12.43% |
| Debt/Equity Ratio | 1.3% |
How did 603367 perform over the long term?
See historical performance and comparisonDividends
3.2%
Current Dividend Yield56%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 11:56 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cisen Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiaxi Xu | Industrial Securities Co. Ltd. |